CNS Pharmaceuticals, Inc.
CNSPNasdaqCIK 1729427HealthcareFiscal year ends Dec 31
Reports and events: 164 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0212:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001683168-26-007552 |
| 2026-08-2121:15 ET | DEF 14A | Proxy statementPeriod 2026-09-30 | 0001683168-26-006660 |
| 2026-08-1211:56 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001683168-26-006224 |
| 2026-07-0211:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-005233 |
| 2026-05-1411:55 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001683168-26-003847 |
| 2026-05-0411:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-26-003432 |
| 2026-04-3020:30 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001683168-26-003374 |
| 2026-03-3120:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001683168-26-002550 |
| 2026-03-1112:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-001664 |
| 2026-03-0222:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-26-001413 |
| 2026-02-1713:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-26-001066 |
| 2025-12-1713:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-25-009208 |
| 2025-11-2122:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001683168-25-008624 |
| 2025-11-1422:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001683168-25-008466 |
| 2025-10-2420:00 ET | DEF 14A | Proxy statementPeriod 2025-11-17 | 0001683168-25-007760 |
| 2025-08-1420:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001683168-25-006162 |
| 2025-07-2220:39 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-005284 |
| 2025-07-1521:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-005129 |
| 2025-05-1521:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001683168-25-003733 |
| 2025-05-1522:52 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-25-003575 |
| 2025-05-1210:03 ET | S-1/A | Registration statement, amended | 0001683168-25-003362 |
| 2025-04-3020:30 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001683168-25-002998 |
| 2025-04-1421:01 ET | S-1 | Registration statement | 0001683168-25-002548 |
| 2025-04-0919:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-002373 |
| 2025-03-3121:12 ET | 8-K | 8.01 Other events | 0001683168-25-002140 |
| 2025-03-3121:11 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001683168-25-002139 |
| 2025-03-2021:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-001754 |
| 2025-02-2122:00 ET | 8-K | 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-001174 |
| 2025-01-0322:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-000077 |
| 2024-12-1117:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-008640 |
| 2024-12-0300:34 ET | 8-K | 5.07 Shareholder vote results | 0001683168-24-008464 |
| 2024-11-1422:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001683168-24-008125 |
| 2024-11-0113:00 ET | 8-K | 8.01 Other events | 0001683168-24-007533 |
| 2024-10-2820:15 ET | DEF 14A | Proxy statementPeriod 2024-11-26 | 0001683168-24-007416 |
| 2024-10-2421:27 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-007371 |
| 2024-10-2312:02 ET | 8-K | 8.01 Other events | 0001683168-24-007304 |
| 2024-09-1820:30 ET | 8-K | 3.01 Delisting notice | 0001683168-24-006495 |
| 2024-09-1212:58 ET | 8-K | 3.01 Delisting notice | 0001683168-24-006318 |
| 2024-08-1421:22 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001683168-24-005711 |
| 2024-08-0711:30 ET | 8-K | 8.01 Other events | 0001683168-24-005311 |
| 2024-08-0220:11 ET | SC 13D | Ownership report, active investor | 0001193125-24-192870 |
| 2024-07-3021:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-005145 |
| 2024-07-3011:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-005118 |
| 2024-07-2612:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-24-005070 |
| 2024-07-2413:30 ET | 8-K | 3.01 Delisting notice | 0001683168-24-005023 |
| 2024-07-1921:12 ET | S-1/A | Registration statement, amended | 0001683168-24-004962 |
| 2024-07-1220:30 ET | S-1 | Registration statement | 0001683168-24-004799 |
| 2024-07-1223:38 ET | 8-K/A | 8.01 Other events | 0001683168-24-004772 |
| 2024-07-0915:25 ET | 8-K | 8.01 Other events | 0001683168-24-004708 |
| 2024-07-0320:56 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-004667 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.